Rogister, Bernard ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie générales, et biochimie humaine
T. Cloughesy The impact of recent data on the optimization of standards of care in newly diagnosed glioblastoma Semin. Oncol. 38 2011 S11 S20
S.J. Schramm, A.E. Campain, R.A. Scolyer, Y.H. Yang, and G.J. Mann Review and cross-validation of gene expression signatures and melanoma prognosis J. Invest. Dermatol. 132 2011 274 283
L.L. Carr, J.H. Finigan, and J.A. Kern Evaluation and treatment of patients with non-small cell lung cancer Med. Clin. North. Am. 95 2011 1041 1054
F. Lefranc, J. Brotchi, and R. Kiss Possible future issues in the treatment of glioblastomas, with a special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis J. Clin. Oncol. 23 2005 2411 2422
M.S. Soengas, and S.W. Lowe Apoptosis and melanoma chemoresistance Oncogene 22 2003 3138 3151
S. Han, and J. Roman Targeting apoptotic signaling pathways in human lung cancer Curr. Cancer Drug Targets 10 2010 566 574
P. Savage, J. Stebbing, M. Bower, and T. Crook Why does cytotoxic chemotherapy cure only some cancers? Nat. Clin. Pract. Oncol. 6 2009 43 52
T.R. Wilson, P.G. Johnston, and D.B. Longley Anti-apoptotic mechanisms of drug resistance in cancer Curr. Cancer Drug Targets 9 2009 307 319
C.E. Griguer, and C.R. Oliva Bioenergetics pathways and therapeutic resistance in gliomas: emerging role of mitochondria Curr. Pharm. Des. 17 2011 2421 2427
C.A. La Porta Mechanism of drug sensitivity and resistance in melanoma Curr. Cancer Drug Targets 9 2009 391 397
G.V. Scagliotti, S. Novello, and G. Selvaggi Multidrug resistance in non-small-cell lung cancer Ann. Oncol. 10 1999 S83 S86
R. Stupp, M.E. Hegi, W.P. Mason, M.J. van den Bent, M.J. Taphoorn, R.C. Janzer, S.K. Ludwin, A. Allgeier, B. Fisher, and K. Belanger Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-years analysis of the EORTC-NCIC trial Lancet Oncol. 10 2009 459 466
F. Lefranc, V. Facchini, and R. Kiss Pro-autophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas Oncologist 12 2007 1395 1403
T. Mijatovic, F. Dufrasne, and R. Kiss Cardiotonic steroids-mediated targeting of the Na+/K+-ATPase to combat chemoresistant cancers Curr. Med. Chem. 19 2012 627 646
F. Lefranc, T. Mijatovic, Y. Kondo, S. Sauvage, I. Roland, O. Debeir, D. Krstic, V. Vasic, P. Gailly, S. Kondo, G. Blanco, and R. Kiss Targeting the alpha-1 subunit of the sodium pump to combat glioblastoma cells Neurosurgery 62 2008 211 221
V. Mathieu, C. Pirker, E. Martin de Lassalle, M. Vernier, T. Mijatovic, N. De Neve, J.F. Gaussin, M. Dehoux, F. Lefranc, W. Berger, and R. Kiss The sodium pump alpha-1 subunit: a disease progression-related target for metastatic melanoma treatment J. Cell. Mol. Med. 13 2009 3960 3972
T. Mijatovic, I. Roland, E. Van Quaquebeke, B. Nilsson, A. Mathieu, F. Van Vynckt, F. Darro, G. Blanco, V. Facchini, and R. Kiss The alpha-1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers J. Pathol. 121 2007 170 179
T. Mijatovic, U. Jungwirth, P. Heffeter, M.A. Hoda, R. Dornetshulber, R. Kiss, and W. Berger The Na+/K+-ATPase is the Achilles heel of multi-drug-resistant cancer cells Cancer Lett. 282 2009 30 34
D.G. Garcia, L.M.F. Amorim, M.V. de Castro Faria, A.S. Freire, R.E. Santelli, C.O. Da Fonseca, T. Quirico-Santos, and P. Burth The anticancer drug perillyl alcohol is a Na/K-ATPase inhibitor Mol. Cell. Biochem. 345 2010 29 34
C.O. Da Fonseca, J.T. Silva, I.R. Lins, M. Simao, A. Arnobio, D. Futuro, and T. Quirico-Santos Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol Invest. New Drugs 27 2009 557 564
C.O. Da Fonseca, M. Simao, I.R. Lins, R.O. Caetano, D. Futuro, and T. Quirico-Santos Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma J. Cancer Res. Clin. Oncol. 137 2011 287 293
P. Dumont, L. Ingrassia, S. Rouzeau, F. Ribaucour, S. Thomas, I. Roland, F. Darro, F. Lefranc, and R. Kiss The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts Neoplasia 9 2007 766 776
L. Ingrassia, F. Lefranc, J. Dewelle, L. Pottier, V. Mathieu, S. Spiegl-Kreinecker, S. Sauvage, M. El Yazidi, M. Dehoux, W. Berger, E. Van Quaquebeke, and R. Kiss Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents J. Med. Chem. 52 2009 1100 1114
G. van Goietsenoven, J. Hutton, J.P. Becker, B. Lallemand, F. Robert, F. Lefranc, C. Pirker, G. Vandenbussche, P. Van Antwerpen, A. Evidente, W. Berger, M. Prévost, J. Pelletier, R. Kiss, T.G. Kinzy, A. Kornienko, and V. Mathieu Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas FASEB J. 24 2010 4575 4584
A. Mathieu, M. Remmelink, N. D'Haene, S. Penant, J.F. Gaussin, R. Van Ginckel, F. Darro, R. Kiss, and I. Salmon Development of a chemoresistant orthotopic human non-small cell lung carcinoma model in nude mice Cancer 101 2004 1908 1918
S.A. Holstein, and R.J. Hohl Monoterpene regulation of Ras and Ras-related protein expression J. Lipid Res. 44 2003 1209 1215
C.O. Da Fonseca, R. Linden, D. Futuro, C.R. Gattass, and T. Quirico-Santos Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol Arch. Immunol. Ther. Exp. 56 2008 267 276
A.T. Parsa, and E.C. Holland Cooperative translational control of gene expression by Ras and Akt in cancer Trends Mol. Med. 10 2004 607 613
H.W. Lo Targeting Ras-Raf-ERK and its interactive pathways as a novel therapy for malignant gliomas Curr. Cancer Drug Targets 10 2010 840 848
D. Thomae, E. Perspicace, Z. Xu, D. Henryon, S. Schneider, S. Hesse, G. Kirsch, and P. Seck One-pot synthesis of new 2,4,5-trisubstituted 1,3-thiazoles and 1,3-selenazoles Tetrahedron 65 2009 2982 2988
D. Thomae, E. Perspicace, S. Hesse, G. Kirsch, and P. Seck Synthesis of substituted [1,3]thiazolo[4,5-b]pyridines and [1,3]thiazolo[4,5-d][1,2,3] triazines Tetrahedron 64 2008 9309 9314
M.P. Doyle, B. Siegfried, and J.F. Dellaria Alkyl nitrite-metal halide deamination reactions. 2. Substitutive deamination of arylamines by alkyl nitrites and copper (II) halides. A direct and remarkably efficient conversion of arylamines to aryl halides J. Org. Chem. 42 1977 2426 2431
A. Begouin, S. Hesse, M.J.R.P. Queiroz, and G. Kirsch Synthesis of diarylamines in the thiophenes series by Buchwald-Hartwig coupling Synthesis 14 2005 2373 2378
K.J. Hodgetts, and M.T. Kershaw Regiocontrolled synthesis of substituted thiazoles Org. Lett. 4 2002 1363 1365
P. Stanetty, T. Dvorak, M.D. Mihovilovic, Synthesis of thieno[2,3-d]thiazole-6-carboxylic acid derivatives as potential inducers of systemic resistance in plants, Arkivoc, part ii, 2001, pp. 34-41.
I.V. Zavarzin, N.G. Smirnova, V.N. Yarovenko, and M.M. Krayushkin Synthesis of thieno[2,3-d]thiazole-2-carboxamides Russ. J. Org. Chem. 40 2004 137 139
S.P.G. Costa, A.M.F. Oliveira-Campos, G. Kirsch, and J. Griffiths Synthesis of thieno[2,3-d]thiazole derived dyes with potential application in nonlinear optics An. Quim. Int. Ed. 94 1998 186 188
S. Athmani, and B. Iddon Azoles. Synthesis of derivatives of thieno[2,3-d]thiazole, 4H-pyrrolo[2,3-d]thiazole, 2H-pyrazolo[3,4-d]thiazole and isoxazolo[3,4-d]thiazole from thiazolidine-2,4-dione J. Chem. Soc. Perkin Trans. 1 8 1992 973 977
S. Athmani, and B. Iddon Azoles. Part 10. Thiazolo[4′,5′;4,5] thieno[3,2-d]pyrimidine, a new heterocyclic ring system Tetrahedron 48 1992 7689 7702
E. Goffin, D. Lamoral-Theys, N. Tajedine, P. de Tullio, L. Mondin, F. Lefranc, P. Gailly, B. Rogister, R. Kiss, and B. Pirotte Benzopyrans display in vitro anticancer activity and selectivity on apoptosis-resistant glioblastoma cells: screening, synthesis of simplified derivatives, and structure-activity relationship analysis Eur. J. Med. Chem. 54 2012 834 844
R. Kiss Hot topics in ion channels and cancers Curr. Med. Chem. 19 2012 625 626
I. Prassas, and E.P. Diamandis Novel therapeutic applications of cardiac glycosides Nat. Rev. Drug Discov. 7 2008 926 935
E.A. Platz, S. Yegnasubramanian, J.O. Liu, C.R. Chong, J.S. Shim, S.A. Kenfield, M.J. Stampfer, W.C. Willet, E. Giovannucci, and W.G. Nelson A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment Cancer Discovery 1 2011 68 77
Z. Li, Z. Zhang, J.X. Xie, X. Li, J. Tian, T. Cai, H. Cui, H. Ding, J.I. Shapiro, and Z. Xie Na/K-ATPase mimetic pNaKtide peptide inhibits the growth of human cancer cells J. Biol. Chem. 286 2011 32393 32403
Z. Xie, and A. Askari Na+/K+-ATPase as a signal transducer Eur. J. Biochem. 269 2002 2434 2439
M. Liang, J. Tian, L. Liu, S. Pierre, J. Liu, J. Shapiro, and Z.J. Xie Identification of a pool of non-pumping Na/K-ATPase J. Biol. Chem. 282 2007 10585 10593
J. Tian, T. Cai, Z. Yuan, H. Wang, L. Liu, M. Haas, E. Maksimova, X.Y. Huang, and Z.J. Xie Binding of Src to Na+/K+-ATPase forms a functional signaling complex Mol. Biol. Cell. 17 2006 317 326
L. Zhang, Z. Zhang, H. Guo, and Y. Wang Na+/K +-ATPase-mediated signal transduction and Na+/K +-ATPase regulation Fundam. Clin. Pharmacol. 22 2008 615 621
J. Jung, H.Y. Kim, M. Kim, K. Sohn, M. Kim, and K. Lee Translationally controlled tumor protein induces human breast epithelial cell transformation through the activation of Src Oncogene 30 2011 2264 2274
D. Upadhyay, E. Lecuona, A. Comellas, D.W. Kamp, and J.L. Sznajder Fibroblast growth factor-10 upregulates Na, K-ATPase via the MAPK pathway FEBS Lett. 545 2003 173 176
P.L. JØrgensen Purification and characterization of (Na +, K+)-ATPase. III. Purification from the outer medulla of mammalian kidney after selective removal of membrane components by sodium dodecylsulphate Biochim. Biophys. Acta 356 1977 36 52
P. Burth, M. Younes-Ibrahim, F.H.F.S. Gonçalez, E.R. Costa, and M.V. Castro Faria Purification and characterization of a Na+, K + ATPase inhibitor found in an endotoxin of leptospira Infect. Immun. 65 1997 2557 2560
G.L. Peterson A simplification of the protein assay method of Lowry et al. which is more generally applicable Anal. Biochem. 83 1977 346 356
G.G. Rodriguez de Lores Arnaiz, T. Herbin, and C. Pena A comparative study between a brain Na+, K+-ATPase inhibitor (endobain E) and ascorbic acid Neurochem. Res. 28 2003 903 910
